Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Research ArticleReview Article

New Era of Lipid-Lowering Drugs

Philip J. Barter and Kerry-Anne Rye
Rhian M. Touyz, ASSOCIATE EDITOR
Pharmacological Reviews April 2016, 68 (2) 458-475; DOI: https://doi.org/10.1124/pr.115.012203
Philip J. Barter
School of Medical Sciences, University of New South Wales, Kensington, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerry-Anne Rye
School of Medical Sciences, University of New South Wales, Kensington, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rhian M. Touyz
School of Medical Sciences, University of New South Wales, Kensington, New South Wales, Australia
Roles: ASSOCIATE EDITOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 68 no. 2 458-475
DOI 
https://doi.org/10.1124/pr.115.012203
PubMed 
26983688

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online March 16, 2016.

Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Philip J. Barter and
  2. Kerry-Anne Rye
  1. School of Medical Sciences, University of New South Wales, Kensington, New South Wales, Australia
  1. Rhian M. Touyz, ASSOCIATE EDITOR
  1. Address correspondence to:
    Philip J. Barter, School of Medical Sciences, University of New South Wales, Kensington, NSW 2033, Australia. E-mail: pbarter{at}ozemail.com.au or p.barter{at}unsw.edu.au
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2018 to September 2023

AbstractFullPdf
Jan 201829922
Feb 20181112449
Mar 2018716166
Apr 2018033848
May 2018116066
Jun 2018217442
Jul 2018213437
Aug 201819924
Sep 2018728245
Oct 2018729241
Nov 2018429424
Dec 2018133122
Jan 2019430121
Feb 2019726921
Mar 2019623453
Apr 2019220667
May 2019120163
Jun 2019320038
Jul 2019018038
Aug 2019417735
Oct 2019317637
Nov 2019913145
Dec 2019109823
Jan 202018525
Feb 2020410037
Mar 202028931
May 2020114923
Jun 202054223
Jul 202013514
Aug 202025311
Sep 202048621
Oct 2020117727
Nov 202035719
Dec 202035219
Jan 202132417
Feb 202122412
Mar 202156929
Apr 202143816
May 202143723
Jun 202173716
Jul 202135428
Aug 202134225
Sep 202114622
Oct 202166447
Nov 202153840
Dec 2021135234
Jan 202264533
Feb 202233723
Mar 2022332836
Apr 202279710
May 202281621
Jun 20225238
Jul 202275418
Aug 202258512
Sep 202268310
Oct 202254229
Nov 202296113
Dec 20225155
Jan 20238149
Feb 20234267
Mar 202381318
Apr 20236927
May 20236668
Jun 20236640
Jul 20237344
Aug 20235725
Sep 20235735

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 68 (2)
Pharmacological Reviews
Vol. 68, Issue 2
1 Apr 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
New Era of Lipid-Lowering Drugs
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleReview Article

New Era of Lipid-Lowering Drugs

Philip J. Barter and Kerry-Anne Rye
Pharmacological Reviews April 1, 2016, 68 (2) 458-475; DOI: https://doi.org/10.1124/pr.115.012203

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleReview Article

New Era of Lipid-Lowering Drugs

Philip J. Barter and Kerry-Anne Rye
Pharmacological Reviews April 1, 2016, 68 (2) 458-475; DOI: https://doi.org/10.1124/pr.115.012203
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. Established Therapies
    • III. New Therapies
    • IV. Conclusions
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PROKINETICIN RECEPTORS AS THERAPEUTIC TARGETS
  • ASO and siRNA drugs for systemic diseases of liver origin
  • β-Arrestins: Structure, Function, and Physiology
Show more Review Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics